Timelines of infection and transmission dynamics of H1N1pdm09 in swine.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2020
Historique:
received: 20 01 2020
accepted: 13 05 2020
revised: 24 08 2020
pubmed: 25 7 2020
medline: 22 9 2020
entrez: 25 7 2020
Statut: epublish

Résumé

Influenza is a major cause of mortality and morbidity worldwide. Despite numerous studies of the pathogenesis of influenza in humans and animal models the dynamics of infection and transmission in individual hosts remain poorly characterized. In this study, we experimentally modelled transmission using the H1N1pdm09 influenza A virus in pigs, which are considered a good model for influenza infection in humans. Using an experimental design that allowed us to observe individual transmission events occurring within an 18-hr period, we quantified the relationships between infectiousness, shed virus titre and antibody titre. Transmission event was observed on 60% of occasions when virus was detected in donor pig nasal swabs and transmission was more likely when donor pigs shed more virus. This led to the true infectious period (mean 3.9 days) being slightly shorter than that predicted by detection of virus (mean 4.5 days). The generation time of infection (which determines the rate of epidemic spread) was estimated for the first time in pigs at a mean of 4.6 days. We also found that the latent period of the contact pig was longer when they had been exposed to smaller amount of shed virus. Our study provides quantitative information on the time lines of infection and the dynamics of transmission that are key parts of the evidence base needed to understand the spread of influenza viruses though animal populations and, potentially, in humans.

Identifiants

pubmed: 32706830
doi: 10.1371/journal.ppat.1008628
pii: PPATHOGENS-D-20-00116
pmc: PMC7446876
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008628

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007031
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L001330/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: Consortium members SB, IB, HE are supported by Defra.

Références

Elife. 2016 Apr 15;5:e12217
pubmed: 27113719
J Virol. 1998 Sep;72(9):7367-73
pubmed: 9696833
Vet Pathol. 2014 Mar;51(2):410-26
pubmed: 24363301
ILAR J. 2015;56(1):44-52
pubmed: 25991697
PLoS Comput Biol. 2012;8(6):e1002588
pubmed: 22761567
Adv Virus Res. 2008;72:127-54
pubmed: 19081490
J Virol. 2012 Dec;86(24):13397-406
pubmed: 23015719
Vet Res. 2011 Dec 20;42:120
pubmed: 22185601
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
Zoonoses Public Health. 2016 May;63(3):234-40
pubmed: 26302164
Vet Res. 2016 Aug 17;47(1):86
pubmed: 27530456
Clin Infect Dis. 2007 Apr 15;44(8):1084-8
pubmed: 17366454
Vet Res. 2016 Oct 20;47(1):103
pubmed: 27765064
Emerg Infect Dis. 2007 Dec;13(12):1871-8
pubmed: 18258038
Clin Infect Dis. 2007 Jul 1;45(1):4-9
pubmed: 17554693
Vet Res. 2013 Sep 04;44:72
pubmed: 24007505
Nat Rev Microbiol. 2008 Jun;6(6):477-87
pubmed: 18533288
J Clin Invest. 1998 Feb 1;101(3):643-9
pubmed: 9449698
Nat Med. 2019 Jun;25(6):962-967
pubmed: 31160818
PLoS One. 2016 Jan 12;11(1):e0146616
pubmed: 26757362
PLoS Comput Biol. 2010 Jan 29;6(1):e1000656
pubmed: 20126529
Influenza Other Respir Viruses. 2016 Jul;10(4):291-300
pubmed: 26611769
PLoS One. 2014 Dec 26;9(12):e115815
pubmed: 25542013
J Infect Dis. 1999 Sep;180(3):586-93
pubmed: 10438343
J Virol. 2010 Jul;84(13):6687-98
pubmed: 20410284
Int J Infect Dis. 2012 Oct;16(10):e714-23
pubmed: 22784546
Anim Health Res Rev. 2011 Dec;12(2):133-48
pubmed: 22152290
Am J Epidemiol. 2008 Apr 1;167(7):775-85
pubmed: 18230677
J Virol. 2011 Mar;85(6):2764-70
pubmed: 21191031
Vet Pathol. 2012 Mar;49(2):344-56
pubmed: 21441112
Trends Microbiol. 2012 Jan;20(1):50-7
pubmed: 22153753
J Virol. 2006 Aug;80(15):7590-9
pubmed: 16840338
J Virol. 2000 Dec;74(24):11825-31
pubmed: 11090182
Stat Med. 2008 Jul 10;27(15):2865-73
pubmed: 17960576

Auteurs

Laetitia Canini (L)

Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.

Barbara Holzer (B)

Mucosal immunology, Pirbright Institute, Woking, United Kingdom.

Sophie Morgan (S)

Mucosal immunology, Pirbright Institute, Woking, United Kingdom.

Johanneke Dinie Hemmink (J)

Mucosal immunology, Pirbright Institute, Woking, United Kingdom.

Becky Clark (B)

Mucosal immunology, Pirbright Institute, Woking, United Kingdom.

Mark E J Woolhouse (MEJ)

Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.

Elma Tchilian (E)

Mucosal immunology, Pirbright Institute, Woking, United Kingdom.

Bryan Charleston (B)

Viral immunology, Pirbright Institute, Woking, United Kingdom.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH